After more than a decade of relentless pursuit, PTC Therapeutics' decision to withdraw its application for Translarna marks a watershed moment for the company and the broader biopharmaceutical landscape for rare diseases. This conclusion to a protracted regulatory saga with the U.S. Food and
The promise of artificial intelligence transforming healthcare into a model of efficiency and precision often overshadows the critical human element required to safely guide these powerful new tools. Many health systems are investing heavily in sophisticated algorithms, believing the technology
The digital records detailing the most intimate aspects of a person’s health journey contain the very clues that could unlock the next generation of medical cures, creating a profound modern paradox between personal privacy and public progress. This intricate challenge is not theoretical for i
The rapid integration of sophisticated artificial intelligence into daily life now extends into one of its most personal and critical domains, with direct-to-consumer health applications promising a new era of accessible medical guidance. The proliferation of artificial intelligence represents a
The once-fragmented landscape of American health data is rapidly coalescing into a unified ecosystem, with the federal government's interoperability framework serving as its powerful gravitational center. A historic milestone announced at the ASTP/ONC 2026 Annual Meeting confirms that the
A striking contradiction is unfolding across the American healthcare landscape, where massive financial investments in artificial intelligence are met with a pervasive uncertainty about the industry's ability to actually use the technology effectively. This growing chasm between ambition and
